Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Back to patent action

<< Previous

Bullboard Posts

Next >>

Post by Pandoraon Jun 29, 2022 12:26am

329 Views

Post# 34789487

Back to patent action

I still do not understand what it all means but it continues to move ahead.
The Notice of Allowance was passed today and has been mailed out:

Transaction History

Mail Notice of Allowance

Date	Transaction Description
06-28-2022	Email Notification
06-28-2022	Mail Notice of Allowance

16/610,991

VACCINE CONTAINING CANCER CELLS INACTIVATED BY PHOTODYNAMIC TREATMENT WITH METAL-BASED COORDINATION COMPLEXES, AND IMMUNOTHERAPY METHOD USING SAME

T1081/20076

Available Documents

Mail Room Date	Document Code	Document Description	Document Category	Page Count
06-28-2022	NOA	Notice of Allowance and Fees Due (PTOL-85)	PROSECUTION	7
06-28-2022	EXIN	Examiner Interview Summary Record (PTOL - 413)	PROSECUTION	1
06-28-2022	892	List of references cited by examiner	PROSECUTION	1
06-28-2022	SRFW	Search information including classification, databases and other search related notes	PROSECUTION	1
06-28-2022	IIFW	Issue Information including classification, examiner, name, claim, renumbering, etc.	PROSECUTION	3
06-28-2022	SRNT	Examiner's search strategy and results	PROSECUTION	1
06-28-2022	1449	List of References cited by applicant and considered by examiner	PROSECUTION	6
06-28-2022	SRNT	Examiner's search strategy and results	PROSECUTION	28
06-28-2022	BIB	Bibliographic Data Sheet	PROSECUTION	1
06-28-2022	1449	List of References cited by applicant and considered by examiner